at Marcello Albanesi Allergology and Immunology Unit, Bari, Italy.
Mauro F. Cardoso Lins
Pediatric Neurologist and MedicalDirector
at the School-Clinic for Autism, member ofthe International Affairs Committee of the AmericanAcademy for Cerebral Palsy and DevelopmentalMedicine, and full member at INSAR (InternationalSociety for Autism Research) and ICNA (InternationalChild Neurology Association), Rio de Janeiro, Brazil.
Sandra Carrillo
MD, Professor and Clinician atthe Faculty
of Medicine Panama University, CoFounder of Medicann Cannabis Clinics, Presidentof the Colombian Medical Cannabis Association,and Presidential Advisor, Panama City, Panama.
Davide Fortin
PhD, University of Lille,
Lille, France.
Valeria Giorgi
MD, Researcher at IRCCS
Istituto Galeazzi-Sant’Ambrogio, Milan, Italy.
Wendy Holden
MBBS, MSc, FRCP, DO, Consultant Rheumatologist
at Sapphire Medical Clinic, NorthHampshire, UK.
Alex Khourdaji
Analysts at ProhibitionPartners
London, UK.
Lawrence Purkiss
Analysts at ProhibitionPartners,
London, UK.
Marcello Albanesi
Clinical Allergist and Fundamental Immunologist
at Marcello Albanesi Allergology and Immunology Unit, Bari, Italy.
Mauro F. Cardoso Lins
Pediatric Neurologist and MedicalDirector
at the School-Clinic for Autism, member ofthe International Affairs Committee of the AmericanAcademy for Cerebral Palsy and DevelopmentalMedicine, and full member at INSAR (InternationalSociety for Autism Research) and ICNA (InternationalChild Neurology Association), Rio de Janeiro, Brazil.
Valeria Giorgi
MD, Researcher at IRCCS
Istituto Galeazzi-Sant’Ambrogio, Milan, Italy.
Wendy Holden
MBBS, MSc, FRCP, DO, Consultant Rheumatologist
at Sapphire Medical Clinic, NorthHampshire, UK.
Janosch Kratz
MD at department of geriatrics
of DRKKlinikum Köpenick (Berlin) and conducting research atthe Centre of Endometriosis of the Charité UniversityHospital in Berlin, Germany. Member of the Spanish PainSociety (SED) and the German Medical Cannabis Society(Deutsche Medizinal-Cannabis Gesellschaft-DMCG)
Guillermo Moreno Sanz,
PhD, Global Scientific Director,
Khiron Life Sciences Corp., Vitoria-Gasteiz, BasqueCountry, Spain
Simon Nicolussi
PhD, Chief Scientific Officer, DASCOLIPharma AG
Zurich, Switzerland, member of SwissSociety of Cannabis in Medicine (SGCM).
at Cannabiscientia SA; CertifiedCannabis Educator and Scientific Advisor atEduCanNation; Toronto, Canada.
Stephen Murphy
CEO & Co-founder
Prohibition Partners,London, United Kingdom
Janosch Kratz
MD at department of geriatrics
of DRKKlinikum Köpenick (Berlin) and conducting research atthe Centre of Endometriosis of the Charité UniversityHospital in Berlin, Germany. Member of the Spanish PainSociety (SED) and the German Medical Cannabis Society(Deutsche Medizinal-Cannabis Gesellschaft-DMCG)
Guillermo Moreno Sanz,
PhD, Global Scientific Director,
Khiron Life Sciences Corp., Vitoria-Gasteiz, BasqueCountry, Spain
Simon Nicolussi
PhD, Chief Scientific Officer, DASCOLIPharma AG
Zurich, Switzerland, member of SwissSociety of Cannabis in Medicine (SGCM).
